HAL Id: hal-02119361
https://hal-amu.archives-ouvertes.fr/hal-02119361
Submitted on 3 May 2019
HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Distributed under a Creative Commons Attribution - NonCommercial| 4.0 International
cohort: a comparison with controls from the French population
Claire Oudin, Julie Berbis, Yves Bertrand, Camille Vercasson, Frederique Thomas, Pascal Chastagner, Stephane Ducassou, Justyna Kanold,
Marie-Dominique Tabone, Catherine Paillard, et al.
To cite this version:
Claire Oudin, Julie Berbis, Yves Bertrand, Camille Vercasson, Frederique Thomas, et al.. Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’
cohort: a comparison with controls from the French population. Haematologica, Ferrata Storti Foun-
dation, 2018, 103 (4), pp.645-654. �10.3324/haematol.2017.176123�. �hal-02119361�
Received: July 10, 2017.
Accepted: January 17, 2018.
Pre-published: January 19, 2018.
©2018 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright.
All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:
https://creativecommons.org/licenses/by-nc/4.0/legalcode.
Copies of published material are allowed for personal or inter- nal use. Sharing published material for non-commercial pur- poses is subject to the following conditions:
https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for com- mercial purposes is not allowed without permission in writing from the publisher.
Correspondence:
gmichel@ap-hm.fr
Ferrata Storti Foundation
Haematologica 2018 Volume 103(4):645-654
ARTICLE
Complications in Hematology
doi:10.3324/haematol.2017.176123
Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures:
www.haematologica.org/content/103/4/645
T he prevalence of the metabolic syndrome among adults from the French LEA childhood acute leukemia survivors’ cohort was prospectively evaluated considering the type of anti-leukemic treatment received, and compared with that of controls. The metabolic profile of these patients was compared with that of controls. A total of 3203 patients from a French volunteer cohort were age- and sex- matched 3:1 to 1025 leukemia survivors (in both cohorts, mean age: 24.4 years; females: 51%). Metabolic syndrome was defined according to the National Cholesterol Education Program’s Adult Treatment Panel III cri- teria. Metabolic syndrome was found in 10.3% of patients (mean fol- low-up duration: 16.3±0.2 years) and 4.5% of controls, (OR=2.49;
P<0.001). Patients transplanted with total body irradiation presented the highest risk (OR=6.26; P<0.001); the other treatment groups also showed a higher risk than controls, including patients treated with chemotherapy only. Odd Ratios were 1.68 (P=0.005) after chemothera- py only, 2.32 (P=0.002) after chemotherapy and cranial irradiation, and 2.18 (P=0.057) in patients transplanted without irradiation. Total body irradiation recipients with metabolic syndrome displayed a unique pro- file compared with controls: smaller waist circumference (91 vs. 99.6 cm;
P=0.01), and increased triglyceride levels (3.99 vs. 1.5 mmol/L; P<0.001), fasting glucose levels (6.2 vs. 5.6 mmol/L; P=0.049), and systolic blood pressure (137.9 vs. 132.8 mmHg; P=0.005). By contrast, cranial irradia- tion recipients with metabolic syndrome had a larger waist circumfer- ence (109 vs. 99.6 cm; P=0.007) than controls. Regardless of the anti- leukemic treatment, metabolic syndrome risk was higher among child- hood leukemia survivors. Its presentation differed depending on the treatment type, thus suggesting a divergent pathophysiology. This study is registered at clinicaltrials.gov identifier: 01756599.
Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population
Claire Oudin,
1,2Julie Berbis,
2Yves Bertrand,
3Camille Vercasson,
2Frédérique Thomas,
4Pascal Chastagner,
5Stéphane Ducassou,
6Justyna Kanold,
7Marie-Dominique Tabone,
8Catherine Paillard,
9Marilyne Poirée,
10Dominique Plantaz,
11Jean-Hugues Dalle,
12Virginie Gandemer,
13Sandrine Thouvenin,
14Nicolas Sirvent,
15Paul Saultier,
1Sophie Béliard,
16Guy Leverger,
8André Baruchel,
12Pascal Auquier,²
Bruno Pannier
4and Gérard Michel
1,21